KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Data as of , from SEC Form 4 filings.
See up to 3 months of KMTS. The 7-day demo opens the 1M and 3M ranges and puts KMTS on your watchlist.
Start 7-day demoData as of , from SEC Form 4 filings.
See up to 3 months of KMTS. The 7-day demo opens the 1M and 3M ranges and puts KMTS on your watchlist.
Start 7-day demo
Raymond W. Cohen - Director
Mary Kay Ladone - DirectorKestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 34 | 261,928 | $6.33M |
| Grant or award | 11 | 420,667 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
54 Form 4 filings on record, the earliest from Jul 17, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Traci S. Umberger - Officer | Grant or award | Common Shares | 25,227 footnote F1 | $0.00 | - | |
| ||||||
| Brian Daniel Webster - Officer | Grant or award | Common Shares | 75,681 footnote F1 | $0.00 | - | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 8,155 | $20.53 footnote F2 | $167K | |
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 6,845 | $21.46 footnote F3 | $147K | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 15,000 | $20.04 footnote F2 | $301K | |
| ||||||
| Raymond W. Cohen | Open-market purchase | Common Shares | 10,000 | $19.98 footnote F1 | $200K | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 15,000 | $20.27 footnote F2 | $304K | |
| ||||||
| Kevin C. Reilly | Grant or award | Common Shares | 8,300 | - footnote F1 | - | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 11,635 | $25.39 footnote F2 | $295K | |
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 3,272 | $26.29 footnote F3 | $86K | |
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 93 | $27.18 footnote F4 | $3K | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 15,000 | $22.80 footnote F2 | $342K | |
| ||||||
| Traci S. Umberger - Officer | Open-market sale | Common Shares | 10,500 | $26.69 footnote F2 | $280K | |
| ||||||
| Brian Daniel Webster - Officer | Open-market sale | Common Shares | 15,000 | $26.59 footnote F2 | $399K | |
| ||||||
| Timothy P. Moran - Officer | Grant or award | Common Shares | 19,557 footnote F1 | - footnote F1 | - | |
| ||||||
| Alfred J. Ford Jr. - Officer | Open-market purchase | Common Shares | 20,000 | $17.00 | $340K | |
| Traci S. Umberger - Officer | Open-market purchase | Common Shares | 13,500 | $17.00 | $230K | |
| Raymond W. Cohen | Open-market purchase | Common Shares | 17,000 | $17.00 | $289K | |
| Raymond W. Cohen | Grant or award | Common Shares | 10,909 | - | - | |
| Conor Hanley | Grant or award | Common Shares | 13,120 | - | - | |
| Elizabeth Kwo | Grant or award | Common Shares | 10,909 | - | - | |
| Mary Kay Ladone | Grant or award | Common Shares | 10,909 | - | - | |
| Jeffrey Lawrence Schwartz | Grant or award | Common Shares | 10,909 | - | - | |
| Raymond W. Cohen | Grant or award | Common Shares | 12,994 | - | - | |
| Brian Daniel Webster - Officer | Grant or award | Common Shares | 88,235 | $0.00 | - | |
| Traci S. Umberger - Officer | Grant or award | Common Shares | 29,412 | $0.00 | - | |
| Vaseem Mahboob - Officer | Grant or award | Common Shares | 22,059 | $0.00 | - | |
| Alfred J. Ford Jr. - Officer | Grant or award | Common Shares | 29,412 | $0.00 | - | |
An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| COHEN RAYMOND W | Officer | 3,330 | $98K | View on EDGAR | |
| Kwo Elizabeth | Officer | 4,010 | $97K | View on EDGAR | |
| Jeffrey Lawrence Schwartz | Director, 10% Stockholder | 3,890 | $98K | View on EDGAR |
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) had 24 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for KMTS runs to 54 Form 4 filings, the earliest from 2025-07-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
No insider purchases of KMTS were filed in the last 90 days. 4 purchases are on record for this company.
34 insider sales of KMTS were filed in the last 90 days, totaling $6.33M.
This page collects KMTS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
